immunology

cost cutting restructuring savings reduce spend
Pharma

InflaRx charts layoffs, cost cuts to lift lead asset's prospects

Roughly 30% of the company’s staff will be laid off, accompanied by “substantial spending reductions,” InflaRx said in its announcement.
Fraiser Kansteiner Jan 8, 2026 11:03am
An arrow incrementally going up stairs before pointing straight up Blue background

Regeneron, AZ regulatory plans bolstered by phase 3 wins

Nov 7, 2025 2:00pm
Massachusetts Massachusetts flag MA MA flag

AbbVie unveils $70M expansion in MA

Oct 1, 2025 9:05am
Novartis

Novartis' BTK inhibitor wins FDA approval in chronic hives

Sep 30, 2025 6:40pm
Sanofi

Sanofi's Wayrilz snags FDA endorsement in ITP

Aug 29, 2025 5:59pm
one white and yellow capsule farther ahead than four other same-colored blue capsules

AbbVie again leads doctors' perception of immunology drugmakers

May 12, 2025 10:53am